An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial (TOSS)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the impact on overall survival of an intensive follow-up protocol (as practiced today at TMH) against a more cost effective follow-up protocol in patients operated for extremity sarcoma.
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | An Adequate Cost Effective Follow Up Protocol For Bone & Soft Tissue Sarcomas - A Prospective Randomized Trial |
- Overall Survival [ Time Frame: Minimum 2 years ] [ Designated as safety issue: No ]
- Disease free survival [ Time Frame: Minimum 2 years ] [ Designated as safety issue: No ]
| Enrollment: | 500 |
| Study Start Date: | January 2006 |
| Estimated Study Completion Date: | December 2014 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1A
Intensive - 3 monthly follow up
|
|
1B
Intensive - 6 monthly follow up
|
|
IIA
Cost Effective - 3 monthly follow up
|
|
IIB
Cost Effective - 6 monthly follow up
|
Detailed Description:
Follow up studies are performed for a variety of reasons. The detection of a recurrence of the index lesion is the foundation of surveillance. Detection of other medical conditions is a secondary benefit. Psychologically, follow up testing can serve as a source of reassurance. Whether an increased frequency of follow up and the use of various expensive imaging modalities for screening and early detection of recurrence actually results in improving overall survival of patients with extremity sarcomas is a question that remains as yet unanswered. Currently followed post -operative surveillance regimes are empirical and vary widely from centre to centre. Allocation of limited health funding should be guided by evidence based recommendations rather than empirical beliefs. An ideal surveillance regime should meet the criteria of easy implementation, accuracy and cost effectiveness.
In a vast country like India where patients often travel thousands of kilometers in their search for quality medical care the frequency of routine follow up visits is as important as studying the role of expensive screening modalities while drawing up guidelines for cost effective follow up strategies.
This study, a prospective randomized controlled trial, attempts to outline guidelines regarding the role of follow up vis a vis frequency and the use of various imaging modalities for early detection of recurrence in improving overall survival of patients with extremity sarcomas.
Eligibility| Ages Eligible for Study: | 1 Year to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients operated for primary or recurrent extremity bone & soft tissue sarcomas
Inclusion Criteria:
- Patients operated for primary or recurrent extremity bone & soft tissue sarcomas.(both limb salvage and amputations)
- Non Metastatic at presentation.
- Patients reliable for follow-up.
Exclusion Criteria:
- Non-extremity sarcomas.
- Metastatic at presentation
- Patients unreliable for follow up.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Dr. Ajay Puri, Professor, Terry Fox Foundation |
| ClinicalTrials.gov Identifier: | NCT00384735 History of Changes |
| Other Study ID Numbers: | TOSS |
| Study First Received: | October 4, 2006 |
| Last Updated: | February 12, 2013 |
| Health Authority: | India: Institutional Review Board |
Keywords provided by Terry Fox Foundation:
|
bone tumor soft tissue tumor |
Additional relevant MeSH terms:
|
Sarcoma Neoplasms, Connective and Soft Tissue Neoplasms by Histologic Type Neoplasms |
ClinicalTrials.gov processed this record on June 18, 2013